These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7491582)

  • 21. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility.
    Trick WE; Weinstein RA; DeMarais PL; Tomaska W; Nathan C; McAllister SK; Hageman JC; Rice TW; Westbrook G; Jarvis WR
    J Am Geriatr Soc; 2004 Dec; 52(12):2003-9. PubMed ID: 15571534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial use and antimicrobial resistance: a population perspective.
    Lipsitch M; Samore MH
    Emerg Infect Dis; 2002 Apr; 8(4):347-54. PubMed ID: 11971765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An alarming problem in the therapy of infective endocarditis: the development of antibiotic-resistant strains].
    Enia F; Bella R; Mineo R; Mizio G; Reina G
    Ital Heart J Suppl; 2005 Mar; 6(3):121-7. PubMed ID: 15875497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients.
    Ray AJ; Pultz NJ; Bhalla A; Aron DC; Donskey CJ
    Clin Infect Dis; 2003 Oct; 37(7):875-81. PubMed ID: 13130397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global reemergence of tuberculosis: are host defense peptides an option to ameliorate disease burden?
    Flores-Valdez MA; Chopra S
    Microb Drug Resist; 2010 Mar; 16(1):1-7. PubMed ID: 19916791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations.
    Hughes JM; Tenover FC
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S131-5. PubMed ID: 8994792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Import of resistant bacteria].
    Bruun JN
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):156. PubMed ID: 11475187
    [No Abstract]   [Full Text] [Related]  

  • 29. Endophytic fungi: a reservoir of antibacterials.
    Deshmukh SK; Verekar SA; Bhave SV
    Front Microbiol; 2014; 5():715. PubMed ID: 25620957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synonymous preparations--good for the Norwegian health services].
    Paulsen S; Brantzeg S
    Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1987-8. PubMed ID: 2363172
    [No Abstract]   [Full Text] [Related]  

  • 31. [IDENTIFICATION OF THE HIGH TUBERCULOSIS-RISK GROUPS IN NORWAY AND ITS PLACE IN THE CONTROL OF TUBERCULOSIS].
    HANSEN OG
    Bull Int Union Tuberc; 1964 Sep; 35():355. PubMed ID: 14269391
    [No Abstract]   [Full Text] [Related]  

  • 32. An unexpected death?
    Berild D
    Tidsskr Nor Laegeforen; 2016 Aug; 136(14-15):1182. PubMed ID: 27554541
    [No Abstract]   [Full Text] [Related]  

  • 33. [Infections caused by multiresistant enterococci in Norway].
    Harthug S; Langeland N; Digranes A; Simonsen GS; Olsvik O; Sundsfjord A; Natås OB; Haarr E; Gaustad P; Høiby EA; Svarva PL
    Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4070-3. PubMed ID: 9844510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S11-9; discussion S64-73. PubMed ID: 16813977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiresistant bacteria in a Scandinavian perspective].
    Kristinsson KG
    Nord Med; 1995; 110(2):42-4, 54. PubMed ID: 7854908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The end of antibiotics? Increasing bacterial resistance in global and Norwegian perspective].
    Jensenius M; von der Lippe B; Melby K; Steinbakk M
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3382-6. PubMed ID: 7491582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
    Cunha BA
    Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.